Ergomed PLC (LSE:ERGO) - Share price - Overview

Stock Report

Ergomed PLC ERGO

Last Price
GBX199.50

Day Change
1.00|0.50%

As of 21/04/2017
17:15:01 BST | GBX
Minimum 15 Minutes Delay.

Last Close198.50p
Day Range198.05 - 201.95
Mkt Cap80.81Mil
52-Wk Range117.00 - 216.88
Yield %0.00
ISINGB00BN7ZCY67
Volume23,759
P/E40.12
P/S1.90
P/CF217.32

Share Price

Total Returns -

 Chg (%)  
More ...
Ergomed PLC- 
 
Financials
201420152016
More ...
Income Statement
Turnover21.1630.18-
Operating Profit0.782.07-
Net Profit0.581.55-
Reported EPS2.305.20-
Balance Sheet
Current Assets10.9213.50-
Non Current Assets10.7611.19-
Total Assets21.6824.69-
Current Liabilities5.767.23-
Total Liabilities6.347.76-
Total Equity15.3416.94-
Cash Flow
Operating Cash Flow0.970.85-
Net Change in Cash2.63-0.60-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20173.306.9038.7828.910.75--
20185.6511.6668.9117.120.25--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
03/04/2017PurchaseMr. Peter George190.00100,000190,000.00
24/05/2016PurchaseStephen Stamp140.00200,000280,000.00
24/05/2016PurchaseMr. Peter George140.00100,000140,000.00
24/05/2016PurchaseDr. Miroslav Reljanovic140.00400,000560,000.00

Company Profile

Ergomed PLC is engaged in providing services to the pharmaceutical industry and develops new drugs. The Company operates in two business divisions namely Services Business and Co-Development Business.

Sector

Biotechnology

Market Position

961 of 1850 Companies

Index

FTSE AIM All Share

Outlook

(28/03/2017) no outlook statement

Next Event 20/06/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)23.9413.7915.90
Div Yld (E)0.003.894.29
PEG (E)0.480.320.96
ROCE0.00179.2018.09
Op Mrgn0.00-7.80-0.74
EPS Grwth50.0672.1428.10
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Peter George
Chief Executive OfficerDr. Miroslav Reljanovic
Chief Financial OfficerStephen Stamp
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.